Immunovant/$IMVT
About Immunovant
Ticker
Industry
Employees
Immunovant Metrics
$3.3B
-
-$2.22
0.71
-
Price and volume
Market cap
$3.3B
Beta
0.71
52-week high
$42.44
52-week low
$22.41
Average daily volume
897K
Financial strength
Current ratio
7.612
Quick ratio
7.124
Total debt to equity
0.01
Management effectiveness
Return on assets (TTM)
-54.54%
Return on equity (TTM)
-92.17%
Valuation
Price to book
7.43
Price to tangible book (TTM)
7.43
Price to free cash flow (TTM)
-12.183
Growth
Earnings per share change (TTM)
12.98%
3-year earnings per share growth (CAGR)
20.31%
What the Analysts think about Immunovant
Analyst Ratings
Immunovant Financial Performance
Income Statement
Q3 24
QoQ growth
$37B
-39.75%
$45B
107.52%
37.65%
6.78%
Immunovant Earnings Performance
Earnings per share (EPS)
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
$3.69
$2.85
$2.45
$2.42
-
$3.55
$2.61
$2.05
$2.31
$3.94
3.94%
9.20%
19.51%
4.63%
-
Immunovant News
Immunovant: Continued FcRn Targeting With IMVT-1402 Pivotal Study
FcRn Inhibitor Market Size, Target Population, Competitive Landscape & Forecast to 2034 - Immunovant Advances FcRn Inhibitor Pipeline with Promising Results and FDA Green Light for Pivotal Trial
Immunovant Provides Development Updates and Reports Financial Results for the Quarter Ended September 30, 2024
FAQs
What’s the current market cap for Immunovant stock?
What is the P/E ratio for Immunovant stock?
Does Immunovant stock pay dividends?
No, Immunovant (IMVT) stock does not pay dividends to its shareholders as of January 15, 2025.
When is the next Immunovant dividend payment date?
Immunovant (IMVT) stock does not pay dividends to its shareholders.
What is the beta indicator for Immunovant?
Immunovant (IMVT) has a beta rating of 0.71. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.